RIGEL PHARMACEUTICALS, INC. (RIGL) Free cash flow 2016–2023
RIGEL PHARMACEUTICALS, INC. (RIGL) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$6.2MFY2023 · since FY2016: -$76.4M → -$6.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$6.2M | +91.7% |
| FY2022 | -$74.4M | -1711.5% |
| FY2021 | $4.6M | +108.6% |
| FY2020 | -$53.6M | -25.9% |
| FY2019 | -$42.6M | +27.8% |
| FY2018 | -$59.0M | +24.7% |
| FY2017 | -$78.4M | -2.5% |
| FY2016 | -$76.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More RIGL financial trends
RIGL RevenueRIGL Net incomeRIGL Net marginRIGL Gross profitRIGL Gross marginRIGL Operating incomeRIGL Operating marginRIGL Operating cash flowRIGL Capital expendituresRIGL Return on equityRIGL Stock buybacksRIGL Dividends paidRIGL Total assetsRIGL Total liabilitiesRIGL Shareholders’ equityRIGL overview →